|
This is an index of adverse event reports related to Lantus (Insulin Glargine). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (864)
Cases resulting in a serious event (824)
Cases resulting in death (83)
Cases resulting in life threatening events (28)
Cases resulting in hospitalization (337)
Cases resulting in disability (32)
Cases resulting in other serious reactions (498)
Below is a sample of adverse event reports reports related to Lantus (Insulin Glargine). For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in 78 year old male receiving Lantus (Insulin Glargine)
Reported by a consumer/non-health professional from Australia on 2007-10-31
Patient: 78 year old male
Adverse reactions / side effects: Lymphoedema, Gastroenteritis Viral
Adverse event resulted in: hospitalization
Suspect drug(s):
Autopen Insulin Injection PEN
Lantus
Start date: 2007-05-18
Adverse event in 40 year old female receiving Lantus (Insulin Glargine)
Reported by a physician from France on 2007-10-31
Patient: 40 year old female
Adverse reactions / side effects: Myalgia, Lipoatrophy
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Lantus (Insulin Glargine)
Other drugs received by patient: Novorapid
Adverse event in 59 year old female receiving Lantus (Insulin Glargine)
Reported by a physician from United Kingdom on 2007-10-31
Patient: 59 year old female, weighing 103.0 kg (226.6 pounds)
Adverse reactions / side effects: Irritable Bowel Syndrome, Condition Aggravated, Hyperhidrosis
Suspect drug(s):
Lantus (Insulin Glargine)
Other drugs received by patient: Captopril; Unknown Drug; Loratadine; Loratadine; Simvastatin; Furosemide; Candesartan Cilexetil; Acetaminophen
Adverse event in 42 year old female receiving Lantus (Insulin Glargine)
Reported by a physician from Germany on 2007-10-31
Patient: 42 year old female, weighing 110.0 kg (242.0 pounds)
Adverse reactions / side effects: Intentional Overdose, Hypoglycaemia, Hypoglycaemic Coma, Suicide Attempt
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Apidra
Indication: Suicide Attempt
Start date: 2007-10-20
Lantus
Indication: Suicide Attempt
Start date: 2007-10-20
Adverse event in female receiving Lantus (Insulin Glargine)
Reported by a individual with unspecified qualification from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Vision Blurred, Diabetic Retinopathy, Blindness Unilateral, Multiple Sclerosis
Suspect drug(s):
Lantus (Insulin Glargine)
Adverse event in 75 year old female receiving Lantus (Insulin Glargine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-30
Patient: 75 year old female
Adverse reactions / side effects: Rash Macular, Rash Pruritic
Suspect drug(s):
Lantus
Dosage: subcutaneous
Indication: Type 1 Diabetes Mellitus
Levemir
Dosage: subcutaneous
Indication: Type 1 Diabetes Mellitus
Adverse event in 69 year old female receiving Lantus (Insulin Glargine)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-30
Patient: 69 year old female, weighing 90.0 kg (198.0 pounds)
Adverse reactions / side effects: Speech Disorder, Hypoglycaemia, Memory Impairment, Injection Site Bruising, Transient Ischaemic Attack
Suspect drug(s):
Lantus (Insulin Glargine)
Other drugs received by patient: Simvastatin; Metformin HCL; Fluoxetine; Omeprazole; Propranolol; Aspirin; Dipyridamole; Telmisartan
Adverse event in 70 year old male receiving Lantus (Insulin Glargine)
Reported by a pharmacist from Australia on 2007-10-30
Patient: 70 year old male
Adverse reactions / side effects: Weight Increased, Dyspnoea, Myocardial Infarction
Adverse event resulted in: death
Suspect drug(s):
Lantus (Insulin Glargine)
Other drugs received by patient: Unknown Drug
Adverse event in 79 year old female receiving Lantus (Insulin Glargine)
Reported by a consumer/non-health professional from Korea, Republic of on 2007-10-29
Patient: 79 year old female, weighing 43.0 kg (94.6 pounds)
Adverse reactions / side effects: Dermatitis, Hyperglycaemia, Atrial Fibrillation
Adverse event resulted in: hospitalization
Suspect drug(s):
Lantus (Insulin Glargine)
Other drugs received by patient: Fastic
Adverse event in male receiving Lantus (Insulin Glargine)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: male
Adverse reactions / side effects: Dyspnoea, Pain, Injection Site Irritation, Muscle Tightness, Cardiac Disorder, Weight Increased, Myalgia, Blood Glucose Decreased, Dysstasia, Gait Disturbance, Myocardial Infarction, Asthenia, Mobility Decreased
Suspect drug(s):
Lantus (Insulin Glargine)
Other drugs received by patient: Lipitor; Actos
Adverse event in 67 year old male receiving Lantus (Insulin Glargine)
Reported by a consumer/non-health professional from Australia on 2007-10-29
Patient: 67 year old male
Adverse reactions / side effects: Nephrolithiasis, Blood Glucose Fluctuation
Adverse event resulted in: hospitalization
Suspect drug(s):
Autopen Insulin Injection PEN
Lantus
Start date: 2006-08-01
Adverse event in 15 year old female receiving Lantus (Insulin Glargine)
Reported by a physician from Brazil on 2007-10-29
Patient: 15 year old female, weighing 60.0 kg (132.0 pounds)
Adverse reactions / side effects: OFF Label USE, Hyperglycaemia, Hypoglycaemia
Suspect drug(s):
Lantus
Start date: 2005-01-01
Optipen (Insulin Pump)
Start date: 2005-01-01
Other drugs received by patient: Humalog
Adverse event in 39 year old female receiving Lantus (Insulin Glargine)
Reported by a physician from Denmark on 2007-10-29
Patient: 39 year old female
Adverse reactions / side effects: Drug Exposure During Pregnancy, Abortion Spontaneous
Suspect drug(s):
Lantus (Insulin Glargine)
Other drugs received by patient: Actrapid
Adverse event in 61 year old male receiving Lantus (Insulin Glargine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-29
Patient: 61 year old male, weighing 104.3 kg (229.5 pounds)
Adverse reactions / side effects: Drug Dose Omission, Medication Error, Hypoglycaemia, Incorrect Dose Administered, Pharmaceutical Product Complaint
Adverse event resulted in: life threatening event
Suspect drug(s):
Humalog
Dosage: 36 units am 25 pm twice a day sq
Indication: Diabetes Mellitus
Start date: 2007-03-16
End date: 2007-10-27
Lantus
Dosage: 65 units twice a day sq
Indication: Diabetes Mellitus
Start date: 2006-10-15
End date: 2007-10-27
Adverse event in 71 year old female receiving Lantus (Insulin Glargine)
Reported by a consumer/non-health professional from Australia on 2007-10-25
Patient: 71 year old female
Adverse reactions / side effects: Dyspnoea, Wheezing, Abasia, Convulsion
Suspect drug(s):
Lantus (Insulin Glargine)
Other drugs received by patient: Novorapid
Adverse event in receiving Lantus (Insulin Glargine)
Reported by a individual with unspecified qualification from Germany on 2007-10-25
Patient: , weighing 125.0 kg (275.0 pounds)
Adverse reactions / side effects: Lung Neoplasm Malignant, Coronary Artery Stenosis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Exubera
Indication: Type 2 Diabetes Mellitus
Start date: 2006-08-11
End date: 2007-10-18
Glucophage
Administration route: Oral
Start date: 2005-08-29
Lantus
Indication: Type 2 Diabetes Mellitus
Start date: 2005-04-26
Other drugs received by patient: Nebilet; Carmen; Sortis; Thioctacid; Aspirin; Coaprovel; Ismo
Adverse event in 66 year old male receiving Lantus (Insulin Glargine)
Reported by a individual with unspecified qualification from United States on 2007-10-25
Patient: 66 year old male
Adverse reactions / side effects: Cerebrovascular Accident, Blood Glucose Increased
Suspect drug(s):
Lantus (Insulin Glargine)
Adverse event in 50 year old male receiving Lantus (Insulin Glargine)
Reported by a consumer/non-health professional from Australia on 2007-10-25
Patient: 50 year old male
Adverse reactions / side effects: Sudden Death
Adverse event resulted in: death
Suspect drug(s):
Autopen Insulin Injection PEN
Lantus
Start date: 2006-09-01
End date: 2007-07-01
Adverse event in 62 year old female receiving Lantus (Insulin Glargine)
Reported by a consumer/non-health professional from South Africa on 2007-10-25
Patient: 62 year old female
Adverse reactions / side effects: Weight Increased
Suspect drug(s):
Apidra
Start date: 2007-05-01
Lantus
Start date: 2007-05-01
Other drugs received by patient: Tareg; Eltroxin; Simvastatin
Adverse event in 76 year old male receiving Lantus (Insulin Glargine)
Reported by a consumer/non-health professional from Australia on 2007-10-24
Patient: 76 year old male
Adverse reactions / side effects: Hospitalisation, Coronary Artery Disease
Adverse event resulted in: hospitalization
Suspect drug(s):
Autopen Insulin Injection PEN
Lantus
Start date: 2004-06-01
Adverse event in 15 year old female receiving Lantus (Insulin Glargine)
Reported by a consumer/non-health professional from Brazil on 2007-10-24
Patient: 15 year old female, weighing 60.0 kg (132.0 pounds)
Adverse reactions / side effects: OFF Label USE, Hospitalisation, Hyperglycaemia, Hypoglycaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Lantus
Start date: 2005-01-01
Optipen (Insulin Pump)
Start date: 2005-01-01
Other drugs received by patient: Humalog
Adverse event in 70 year old female receiving Lantus (Insulin Glargine)
Reported by a physician from Turkey on 2007-10-24
Patient: 70 year old female, weighing 77.0 kg (169.4 pounds)
Adverse reactions / side effects: Dyspnoea, Nausea, Hyperglycaemia, Sense of Oppression, Renal Failure, Cardiac Failure, Cardiac Arrest, Pharmaceutical Product Complaint
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Lantus
Start date: 2000-01-01
End date: 2007-07-01
Lantus
Start date: 2000-01-01
End date: 2007-07-01
Optipen (Insulin Pump)
Start date: 2000-01-01
End date: 2007-07-01
Other drugs received by patient: Cipram; Zocor; Ketosteril / 00512401 /; Promid / 00046201 /; Ecopirin
Adverse event in female receiving Lantus (Insulin Glargine)
Reported by a consumer/non-health professional from United Kingdom on 2007-10-24
Patient: female
Adverse reactions / side effects: Diabetic Ketoacidosis, Pharmaceutical Product Complaint, Blood Glucose Increased, Loss of Consciousness
Adverse event resulted in: hospitalization
Suspect drug(s):
Lantus (Insulin Glargine)
Adverse event in male receiving Lantus (Insulin Glargine)
Reported by a consumer/non-health professional from United States on 2007-10-24
Patient: male
Adverse reactions / side effects: Dyspnoea, Injection Site Irritation, Muscle Tightness, Blood Glucose Decreased, Myalgia, Dysstasia, Asthenia, Myocardial Infarction, Mobility Decreased
Suspect drug(s):
Lantus (Insulin Glargine)
Other drugs received by patient: Medication NOT Specified
Adverse event in 54 year old male receiving Lantus (Insulin Glargine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-24
Patient: 54 year old male, weighing 111.8 kg (246.0 pounds)
Adverse reactions / side effects: Hypoglycaemic Unconsciousness, Wrong Drug Administered
Suspect drug(s):
Insulin Lispro
Start date: 2002-08-19
Lantus
Start date: 2002-08-19
Other drugs received by patient: Acetylsalicylic Acid SRT; Ezetimibe; Simvastatin; Fexofenadine Hydrochloride; Omeprazole; Ramipril
|
